Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A SUV<sub>max</sub>-based propensity matched analysis of stereotactic body radiotherapy versus surgery in stage I non-small cell lung cancer: unveiling the role of 18F-FDG PET/CT in clinical decision-making.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2018
Same author

Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2018
Same author

[Clinical efficacy of one-lung ventilation in treatment of children postoperatively intractable atelectasis].

Zhonghua er ke za zhi = Chinese journal of pediatrics·2017
Same author

Long noncoding RNA CASC2 inhibits metastasis and epithelial to mesenchymal transition of lung adenocarcinoma via suppressing SOX4.

European review for medical and pharmacological sciences·2017
Same author

Hyperandrogenism stimulates inflammation and promote apoptosis of cumulus cells.

Cellular and molecular biology (Noisy-le-Grand, France)·2017
Same author

Impact of varicocelectomy on the proteome profile of testicular tissues of rats with varicocele.

Andrologia·2017

Related Experiment Video

Updated: May 4, 2026

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

6.4K

Engineering three-dimensional cardiac microtissues for potential drug screening applications.

L Wang, G Huang, B Sha

  • 1Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an, China 710049. wwgyhuang@mail.xjtu.edu.cn.

Current Medicinal Chemistry
|December 24, 2013
PubMed
Summary

Three-dimensional cardiac microtissue (CMT) models offer improved in vitro platforms for studying heart disease mechanisms and screening cardiovascular drugs. These advanced models better mimic native heart tissue than traditional 2D cultures.

More Related Videos

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

4.5K
Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

5.7K

Related Experiment Videos

Last Updated: May 4, 2026

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

6.4K
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

4.5K
Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

5.7K

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Tissue Engineering

Background:

  • Heart disease remains a leading global health challenge, with limited cures despite advances in cardiac tissue engineering.
  • Current limitations stem from poor understanding of disease mechanisms and a lack of effective in vitro models for drug screening.

Purpose of the Study:

  • To review the development of three-dimensional (3D) cardiac microtissue (CMT) models.
  • To highlight the potential of 3D CMT models for cardiovascular drug screening.

Main Methods:

  • Development of microengineering technologies for creating 3D cardiac microtissues.
  • Mimicking the 3D architectural microenvironment of native heart tissues.

Main Results:

  • Engineered 3D CMT models closely replicate the native heart tissue microenvironment.
  • 3D CMT models show greater potential for drug assessment compared to traditional 2D cardiomyocyte cultures.

Conclusions:

  • 3D CMT models represent a significant advancement over traditional models for cardiovascular research.
  • These models hold promise for high-throughput screening of cardiovascular drug candidates, potentially accelerating therapeutic development.